Literature DB >> 22294398

Acute seizure tests in epilepsy research: electroshock- and chemical-induced convulsions in the mouse.

William J Giardina1, Maciej Gasior.   

Abstract

Epilepsy is a common (50 million patients worldwide) neurological disorder characterized by seizures that are caused by episodic abnormal electrical activity in the brain. Animal models play an essential role in epilepsy research including the discovery and development of new antiepileptic drugs. Described in this unit are protocols for traditional acute tests in which seizures are induced by either an electrical stimulation or a convulsant agent in non-epileptic mice. Specifically, protocols for the following acute seizure tests are provided: the maximal electroshock induced test (MES), the maximal electroshock seizure threshold (MEST) test, the 6-Hz seizure test, the subcutaneous pentylenetetrazol (s.c. PTZ) seizure test, and the intravenous pentylenetetrazol (i.v. PTZ) seizure test. These tests can be used to characterize anticonvulsant and/or proconvulsant properties of compounds in mice. The MES, s.c. PTZ, and 6-Hz seizure tests represent the three most widely used animal tests in drug-screening programs. Although the parameters of these tests are optimized for mice, the same tests (except for the 6-Hz seizure test), with some modifications, can be used with rats.
© 2009 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22294398     DOI: 10.1002/0471141755.ph0522s45

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  14 in total

1.  Anticonvulsant activity of fraction isolated from ethanolic extract of heartwood of Cedrus deodara.

Authors:  Daniel Dhayabaran; Ebinezar Jeyaseeli Florance; Krishnadas Nandakumar; Alagarsamy Shanmugarathinam; Ayarivan Puratchikody
Journal:  J Nat Med       Date:  2014-04       Impact factor: 2.343

2.  Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats.

Authors:  Ashish Dhir; Michael A Rogawski
Journal:  Epilepsia       Date:  2018-04-06       Impact factor: 5.864

3.  Glycine transporter 1 is a target for the treatment of epilepsy.

Authors:  Hai-Ying Shen; Erwin A van Vliet; Kerry-Ann Bright; Marissa Hanthorn; Nikki K Lytle; Jan Gorter; Eleonora Aronica; Detlev Boison
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

4.  Neuroprotective Effect of Lercanidipine- A Novel Calcium Channel Blocker in Albino Mice.

Authors:  Nitya Selvaraj; Mangaiarkkarasi Adhimoolam; Deepa Kameswari Perumal; Meher Ali Rajamohammed
Journal:  J Clin Diagn Res       Date:  2015-11-01

5.  Clavulanic acid does not affect convulsions in acute seizure tests in mice.

Authors:  Maciej Gasior; Katarzyna Socała; Dorota Nieoczym; Piotr Wlaź
Journal:  J Neural Transm (Vienna)       Date:  2011-06-03       Impact factor: 3.575

6.  Anti-kindling effect of Ginkgo biloba leaf extract and L-carnitine in the pentylenetetrazol model of epilepsy.

Authors:  Amina E Essawy; Soad Ahmed El-Sayed; Ehab Tousson; Horeya S Abd El-Gawad; Reem Hasaballah Alhasani; Heba-Tallah Abd Elrahim Abd Elkader
Journal:  Environ Sci Pollut Res Int       Date:  2022-02-22       Impact factor: 5.190

7.  Insights from zebrafish and mouse models on the activity and safety of ar-turmerone as a potential drug candidate for the treatment of epilepsy.

Authors:  Adriana Monserrath Orellana-Paucar; Tatiana Afrikanova; Joice Thomas; Yelaman K Aibuldinov; Wim Dehaen; Peter A M de Witte; Camila V Esguerra
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

8.  Neuropharmacological characterization of the oneirogenic Mexican plant Calea zacatechichi aqueous extract in mice.

Authors:  Maciej Sałaga; Jakub Fichna; Katarzyna Socała; Dorota Nieoczym; Mateusz Pieróg; Marta Zielińska; Anna Kowalczuk; Piotr Wlaź
Journal:  Metab Brain Dis       Date:  2016-01-28       Impact factor: 3.584

9.  Modulating Behavior in C. elegans Using Electroshock and Antiepileptic Drugs.

Authors:  Monica G Risley; Stephanie P Kelly; Kailiang Jia; Brock Grill; Ken Dawson-Scully
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

10.  SIRT5 Deficiency Enhances Susceptibility to Kainate-Induced Seizures and Exacerbates Hippocampal Neurodegeneration not through Mitochondrial Antioxidant Enzyme SOD2.

Authors:  Fengling Li; Lei Liu
Journal:  Front Cell Neurosci       Date:  2016-06-27       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.